Terms: = Gastric cancer AND AFP, AFPD, FETA, HPAFP AND Treatment
116 results:
1. Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.
Zhang J; Wang L; Zhang S; Cao R; Zhao Y; Zhao Y; Song Y; Guo Z
BMC Cancer; 2024 Feb; 24(1):266. PubMed ID: 38408930
[TBL] [Abstract] [Full Text] [Related]
2. Prediction Model of Ocular Metastases in gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study.
Zou J; Shen YK; Wu SN; Wei H; Li QJ; Xu SH; Ling Q; Kang M; Liu ZL; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Technol Cancer Res Treat; 2024; 23():15330338231219352. PubMed ID: 38233736
[No Abstract] [Full Text] [Related]
3. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
[No Abstract] [Full Text] [Related]
4. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract] [Full Text] [Related]
5. A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.
Huang B; Ding F; Li Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15845-15854. PubMed ID: 37672074
[TBL] [Abstract] [Full Text] [Related]
6. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
7. [A Patient with afp-Producing gastric cancer and Stenosis Who Regained Oral Intake Capabilities after T-DXd treatment].
Amagai H; Sasagawa S; Koide Y; Tsukamoto S; Miyazawa Y; Yamakawa H; Murayama H; Sentsui T; Matsubara H; Yamazaki K; Yarita T
Gan To Kagaku Ryoho; 2023 Jul; 50(7):813-816. PubMed ID: 37496227
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of influencing factors of nerve invasion in locally advanced gastric cancer.
Ren XC; Liang P
Abdom Radiol (NY); 2023 Sep; 48(9):3005-3011. PubMed ID: 37289214
[TBL] [Abstract] [Full Text] [Related]
10. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract] [Full Text] [Related]
11. Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.
Akabane M; Yago A; Haruta S; Ohkura Y; Ueno M; Udagawa H
Langenbecks Arch Surg; 2023 Jan; 408(1):66. PubMed ID: 36695913
[TBL] [Abstract] [Full Text] [Related]
12. treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
Kamiimabeppu D; Wakatsuki T; Takahari D; Fukuda N; Shimozaki K; Osumi H; Nakayama I; Ogura M; Ooki A; Shinozaki E; Chin K; Yamaguchi K
Int J Clin Oncol; 2023 Jan; 28(1):121-129. PubMed ID: 36409433
[TBL] [Abstract] [Full Text] [Related]
13. A new biomarker for the early diagnosis of gastric cancer: gastric juice- and serum-derived SNCG.
Pan Y; Zheng Y; Yang J; Wei Y; Wu H; Liu S; Yin A; Hu J; Zeng Y
Future Oncol; 2022 Sep; 18(28):3179-3190. PubMed ID: 35947016
[TBL] [Abstract] [Full Text] [Related]
14. Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis.
Zhang Z; Miao L; Wang S; Zhao Y; Xie Y; Yun H; Ren Z; Wang G; Teng M; Li Y
World J Surg Oncol; 2022 Jun; 20(1):204. PubMed ID: 35710379
[TBL] [Abstract] [Full Text] [Related]
15. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review.
Sun Y; Chang W; Yao J; Liu H; Zhang X; Wang W; Zhao K
J Int Med Res; 2022 Apr; 50(4):3000605221091095. PubMed ID: 35469480
[TBL] [Abstract] [Full Text] [Related]
16. Effect of Apatinib Combined with Seggio on the Expression of Serum afp and CA724 and Long-Term Survival Rate in Patients with Advanced gastric cancer Undergoing Comfortable Nursing Intervention.
Ren D; Feng M; Zhang S; Zhang Y; Li J
J Healthc Eng; 2022; 2022():2004973. PubMed ID: 35432838
[TBL] [Abstract] [Full Text] [Related]
17. C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.
Zhang Y; Lu L; He Z; Xu Z; Xiang Z; Nie RC; Lin W; Chen W; Zhou J; Yin Y; Xie J; Zhang Y; Zheng X; Zhu T; Cai X; Li P; Chao X; Cai MY
Front Immunol; 2022; 13():808101. PubMed ID: 35185894
[TBL] [Abstract] [Full Text] [Related]
18. gastric adenocarcinoma with germ cell tumor components: a rare case report.
Han X; Wang S; He H; Sun Y; Li J
J Int Med Res; 2022 Jan; 50(1):3000605211069202. PubMed ID: 34986675
[TBL] [Abstract] [Full Text] [Related]
19. Both the serum afp test and afp/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract] [Full Text] [Related]
20. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
[TBL] [Abstract] [Full Text] [Related]
[Next]